Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Gamma-glutamyltransferase 3 pseudogene (GGT3P) is a human gene classified as a pseudogene, meaning it has a similar sequence to gamma-glutamyltransferase family genes but is not translated into a functional enzyme or protein. It is located on chromosome 22 and is annotated based on sequence homology to potentially enable glutathione hydrolase activity and participate in peptide modifications and the glutathione catabolic process; however, these are predicted bioinformatically, not demonstrated experimentally. GGT3P does not have a known biological function, does not encode an active protein, is not a therapeutic target, and is commonly misidentified due to similarity in name to active gamma-glutamyltransferases involved in glutathione metabolism and drug detoxification. Key clarification: The confusion often arises because the gamma-glutamyltransferase family includes several functional enzymes (e.g., GGT1) that play important biological and clinical roles, but GGT3P is a non-coding, non-functional pseudogene.
Not applicable for GGT3P as it is not a drug target or functional molecule
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Gamma-glutamyltransferase 3 pseudogene (GGT3P).